DOCSLIB.ORG

Inducing Puberty

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Inducing Puberty European Journal of Endocrinology (2008) 159 S9–S15 ISSN 0804-4643 Inducing puberty Eveline M Delemarre1, Bram Felius2 and Henriette A Delemarre-van de Waal2 1Medical School Leiden and 2Department of Pediatrics, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands (Correspondence should be addressed to H A Delemarre-van de Waal; Email: [email protected]) Abstract Puberty is the result of increasing pulsatile secretion of the hypothalamic gonadotropin releasing hormone (GnRH), which stimulates the release of gonadotropins and in turn gonadal activity. In general in females, development of secondary sex characteristics due to the activity of the gonadal axis, i.e., the growth of breasts, is the result of exposure to estrogens, while in boys testicular growth is dependent on gonadotropins and virilization on androgens. Hypogonadotropic hypogonadism is a rare disease. More common is the clinical picture of delayed puberty, often associated with a delay of growth and more often familial occurring. Especially, boys are referred because of the delay of growth and puberty. A short course (3–6 months) of androgens may help these boys to overcome the psychosocial repercussions, and during this period an increase in the velocity of height growth and some virilization will occur. Hypogonadotropic hypogonadism may present in a congenital form caused by developmental disorders, some of which are related to a genetic disorder, or secondary to hypothalamic–pituitary dysfunction due to, among others, a cerebral tumor. In hypogonadotropic hypogonadism puberty can be initiated by the use of pulsatile GnRH, gonadotropins, and sex steroids. Sex steroids will induce development of the secondary sex characteristics alone, while combined administration of gonadotropins and GnRH may induce gonadal development including fertility. European Journal of Endocrinology 159 S9–S15 Introduction The GnRH test is often used as a diagnostic tool in the evaluation of delayed puberty. However, the response of Pubertal development is the result of increasing release gonadotropins to an acute challenge of GnRH can be of GnRH by the hypothalamus, which in turn increas- difficult to interpret, since in the pre-pubertal state the ingly stimulates the pituitary to release both gonado- pituitary, although intact, will not or hardly respond, tropins LH and FSH. The gonadotropins stimulate the similar to the situation in hypogonadotropic hypogo- gonads, ovary, and testis, to develop and produce the sex nadism (7). Repetitive administration of GnRH intrave- steroids estrogens and androgens respectively. At the nously does increase gonadotropin levels in patients in a onset of puberty, the first endocrine change is the pre-pubertal and hypogonadotropic state. Therefore, occurrence of an LH increase only during the night (1). this diagnostic test is not able to differentiate between With the progression of puberty, the LH pulse pattern the two conditions. In fact, the response to the GnRH shows an increase in frequency and amplitude with a test reflects the measure of previous stimulation by clear day/night rhythm (2). In adulthood, the day/night GnRH. rhythm has disappeared. The pulsatile pattern of LH The GnRH agonist test has been described to be an reflects the pulsatile release of GnRH. For FSH, a pulsatile alternative test in the diagnosis of hypogonadotropic secretion pattern in blood is hard to detect, presumably hypogonadism (8). However, for both the native GnRH due to the longer half-life of 4–6 h of FSH compared with and the GnRH agonist tests, the authors describe 20–30 min for LH (3, 4). In boys, the nocturnal LH significantly higher levels of LH and FSH levels in increase is associated with a concomitant increase in delayed puberty compared with hypogonadotropic testosterone, while in girls the highest estradiol increase patients. We therefore must conclude that there still is occurs during the day as a result of delayed response of no reliable test for differentiation in the pre-pubertal the ovaries (2, 5, 6). state between normal, but delayed puberty and hypogonadotropic hypogonadism. This paper was presented at the 5th Ferring International Paediatric However, clinical aspects such as the family history, Endocrinology Symposium, Baveno, Italy (2008). Ferring Pharma- height growth, and skeletal age can make a given ceuticals has supported the publication of these proceedings. diagnosis more probable. A patient with delayed puberty q 2008 European Society of Endocrinology DOI: 10.1530/EJE-08-0314 Online version via www.eje-online.org Downloaded from Bioscientifica.com at 09/30/2021 10:39:04AM via free access S10 E M Delemarre and others EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008) 159 mostly has a pre-pubertal dip, i.e., a decrease in height development. With respect to pubertal arrest, mutations growth velocity preceding the pubertal growth spurt, and polymorphisms in gonadotropin genes and their while hypogonadotropic patients tend to continue their receptors can be responsible for this phenotype or for growth with pre-pubertal height growth velocity. In complete hypogonadotropic hypogonadism. addition, in delayed puberty,skeletal age will be retarded, The congenital form of hypogonadism may be but conforms to the biological physical status, while in suspectedinthenewbornwithmultiplepituitary hypogonadotropic hypogonadism, skeletal age will start deficiencies. Cryptorchidism and a micropenis may be to delay from the age of onset of puberty and this delay presenting symptoms in boys. The first months can be increases, but finally remains not in conformity with the used to diagnose a GnRH deficiency, since there is a biological, pre-pubertal status of the patient. spontaneous GnRH-related gonadotropin increase. Absence of this gonadotropin peak confirms hypogona- dotropic hypogonadism (10). Kallmann syndrome, hypogonadotropic hypogonad- Pathophysiology of hypogonadotropic ism in combination with anosmia, is the result of a hypogonadism genetic disorder. An X-linked form, an autosomal dominant and an autosomal recessive form are identi- Timing of puberty is the result of both genetic fied. A mutation of the KAL1 gene located on the Xp22.3 constitution and environmental influences. Well region encoding for the protein anosmin has been known is the familial nature of delayed puberty, detected. Anosmin is involved in the neuronal migration whereby mothers exhibit a late menarche and/or and axonal path finding. In the absence of anosmin, fathers always belong to the shortest adolescents during migration of the GnRH releasing, as well as of the their first years in high school, but reach a final height olfactory neurons, cannot be completed, resulting in within the normal range. Chronic systemic diseases hypogonadotropic hypogonadism and anosmia (11). such as Crohn’s disease and asthma are often associated The autosomal form of Kallmann syndrome is the result with delayed puberty. It appears that under these of a mutation of a gene encoding the fibroblastic growth circumstances the body does not expend energy on factor receptor 1 located on the short arm of chromo- growth, puberty, and fertility. Cure will result in the some 8 (12). For the autosomal recessive form, no catchup of growth and progression of the develop- genetic mutation has been identified yet. mental process. Downstream to the GnRH neurons, receptor abnorm- Delayed puberty is defined as the start of puberty at a alities may be responsible for partial to complete forms chronological age older than C2 S.D.ofaverage of hypogonadotropic hypogonadism. Inactivating maturers: from the Dutch data, for boys, when testicular mutations of the GnRH receptors result in the absent growth (testes volume 4 ml or more) has not started at to low pulsatile levels of gonadotropins in combination the age of 14 years, and for girls, when breast with low sex steroid levels. These patients show an development is not present at the age of 13 years or inadequate response to exogenous pulsatile GnRH. menarche did not occur at the age of 15 years. Throughout Europe, there are only slight differences (9). The NR0B1 gene is involved in the development and Hypogonadotropic hypogonadism can develop first due function of the adrenal gland, as well as the hypo- to a developmental abnormality or secondly due to an thalamic–pituitary axis related to gonadotropin underlying disease interfering with the function of the secretion. Mutations of the NR0B1 gene may present hypothalamic–pituitary axis such as a cerebral tumor with an X-linked congenital adrenal hypoplasia and (Table 1). Also, a pubertal arrest may result in lack of pubertal development in boys. With NR0B1 hypogonadotropic hypogonadism after some spontaneous gene mutation, heterozygous girls may have delayed puberty (13). GPR54 is described as a novel regulator of the central Table 1 Causes of hypogonadotropic hypogonadism. control of puberty. The GPR54 gene encodes for a Primary/congenital: G-protein-coupled receptor. Patients with mutations of Idiopathic the GPR54 gene have hypogonadotropic hypogonad- Mutations of LH b and FSH b-subunits ism, while they do respond to exogenous pulsatile GnRH Kallmann syndrome GnRH receptor gene mutations stimulation. In affected mice, GnRH levels at the NR0B1 gene mutation hypothalamic level are normal. Therefore, it appears GPR54 gene mutation that GPR54 is not involved in the production, but in the Transcription factor genes mutation: PROP1, LHX3, and HESX1, release of GnRH (14). in combination with other pituitary hormone deficiencies
Load more

Recommended publications
  • Pulsatile Release of Bioactive Luteinizing Hormone in Prepubertal Girls: Discordance with Immunoreactive Luteinizing Hormone Pulses
    003 I-399818712 104-0409$02.00/0 PEDIATRIC RESEARCH Vol. 21, No. 4, 1987 Copyright O 1987 International Pediatric Research Foundation, Inc I'rfnied in U.S. A. Pulsatile Release of Bioactive Luteinizing Hormone in Prepubertal Girls: Discordance with Immunoreactive Luteinizing Hormone Pulses EDWARD 0. REITER, DARLENE E. BIGGS, JOHANNES D. VELDHUIS, AND INESE Z. BEITINS Department of Pediatrics, Baystate Medical Center, SpringJield, Massachusetts 01 199 [E.O.R., D.E.B.]; Department of Medicine, University of Virginia Medical School, Charlottesville, Virginia 22908 [J.D.V.]; and Department qf Pediatrics of the University of Michigan Medical Center, Ann Arbor, Michigan 48109 [I.Z.B.] ABSTRACT. An assessment of pulsatile secretion of lu- the onset of puberty is an increase in the frequency, as well as teinizing hormone (LH), measured by both immunoassay amplitude, of GnRH pulses from the hypothalamus which is (I-LH) and rat interstitial cell testosterone production translated into gonadotropin secretory pulses from the pituitary. bioassay (B-LH), as well as of folicle-stimulating hormone Increased LH pulse frequency and amplitude, as measured by I- and glycoprotein hormone a-subunit was carried out in LH have been demonstrated in early pubertal children (1-4). In seven normal prepubertal and six normal premenarcheal addition, the mean I-LH levels have been shown to rise with pubertal girls. Samples were obtained at 20-min intervals advancement of puberty in both cross-sectional and longitudinal for a 6-h period. The hormone secretion profiles were studies (5, 6). analyzed by several computerized methods yielding pulse Pituitary gonadotropins are known to be heterogeneous.
    [Show full text]
  • Signature Redacted May 14,2014 Certified By
    System Identification of Cortisol Secretion: Characterizing Pulsatile Dynamics OF TECHNOLOGy by Rose Taj Faghih JUN 1 0 2014 B.S., Electrical Engineering (2008) University of Maryland, College Park LIBRARIES S.M., Electrical Engineering and Computer Science (2010), Massachusetts Institute of Technology Submitted to the Department of Electrical Engineering and Computer Science in partial fulfillment of the requirements for the degree of Doctor of Philosophy at the MASSACHUSETTS INSTITUTE OF TECHNOLOGY June 2014 @ Massachusetts Institute of Technology 2014. All rights reserved. Signature redacted Author ........... ............................. Department of Electrical Engineering and Computer Science Signature redacted May 14,2014 Certified by........ .................................... Emery N. Brown Edward Hood Taplin Professor of Medical Engineering Professor of Computational Neuroscience Thesis Supervisor Certified by Si onRtIIm mdRctE~d Munther A. Dahleh Professor of Electrical Engineering and Computer Science Professor of Engineering Systems Division Thesis Supervisor b Signature redacted,; A cce;pte d Uy .... ....... 4, ..... ...... .. .... S/Prdsar Leslie A. Kolodziejski Chair, Department Committee on Graduate Students System Identification of Cortisol Secretion: Characterizing Pulsatile Dynamics by Rose Taj Faghih Submitted to the Department of Electrical Engineering and Computer Science on May 14, 2014, in partial fulfillment of the requirements for the degree of Doctor of Philosophy Abstract Cortisol controls the body's metabolism and response to inflammation and stress. Cortisol is released in pulses from the adrenal glands in response to pulses of adreno- corticotropic hormone (ACTH) released from the anterior pituitary; in return, cortisol has a negative feedback effect on ACTH release. Modeling cortisol secretion and the interactions between ACTH and cortisol allows for quantifying normal and abnormal physiology and can potentially be used for diagnosis and optimal treatment of some cortisol disorders.
    [Show full text]
  • An Optimization Formulation for Characterization of Pulsatile Cortisol Secretion
    An optimization formulation for characterization of pulsatile cortisol secretion The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Faghih, Rose T. et al. "An optimization formulation for characterization of pulsatile cortisol secretion." Frontiers in Neuroscience 9 (August 2015): 228 © 2015 Faghih, Dahleh and Brown As Published http://dx.doi.org/10.3389/fnins.2015.00228 Publisher Frontiers Research Foundation Version Final published version Citable link http://hdl.handle.net/1721.1/112222 Terms of Use Creative Commons Attribution 4.0 International License Detailed Terms http://creativecommons.org/licenses/by/4.0/ ORIGINAL RESEARCH published: 11 August 2015 doi: 10.3389/fnins.2015.00228 An optimization formulation for characterization of pulsatile cortisol secretion Rose T. Faghih 1, 2, 3, 4*, Munther A. Dahleh 1, 4, 5, 6 and Emery N. Brown 2, 3, 7, 8 1 Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA, USA, 2 Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA, 3 Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA, 4 Laboratory for Information and Decision Systems, Massachusetts Institute of Technology, Cambridge, MA, USA, 5 Engineering Systems Division, Massachusetts Institute of Technology, Cambridge, MA, USA, 6 Institute for Data, Systems, and Society, Massachusetts Institute of Technology, Cambridge, MA, USA, 7 Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA, 8 Department of Anesthesia, Harvard Medical School, Boston, MA, USA Edited by: Jason Ritt, Cortisol is released to relay information to cells to regulate metabolism and reaction Boston University, USA to stress and inflammation.
    [Show full text]
  • Gonadotropin-Releasing Hormone Secretion Into Third
    BIOLOGY OF REPRODUCTION 59, 676±683 (1998) Gonadotropin-Releasing Hormone Secretion into Third-Ventricle Cerebrospinal Fluid of Cattle: Correspondence with the Tonic and Surge Release of Luteinizing Hormone and Its Tonic Inhibition by Suckling and Neuropeptide Y1 O.S. Gazal,3 L.S. Leshin,4 R.L. Stanko,3 M.G. Thomas,5 D.H. Keisler,6 L.L. Anderson,7 and G.L. Williams2,3 Animal Reproduction Laboratory,3 Texas A&M University Agricultural Research Station, Beeville, Texas 78102 USDA/ARS Russell Agricultural Research Center,4 Athens, Georgia 30613 Department of Animal and Range Sciences,5 New Mexico State University, Las Cruces, New Mexico 88003 Department of Animal Science,6 University of Missouri, Columbia, Missouri 65211 Department of Animal Science,7 Iowa State University, Ames, Iowa 50011 ABSTRACT [1]. Although a transnasal, transsphenoidal approach has been described for collecting mixed hypophyseal portal and Objectives of the current studies were to characterize the cavernous sinus blood in ewes and young calves to monitor pattern of GnRH secretion in the cerebrospinal ¯uid of the bo- vine third ventricle, determine its correspondence with the tonic GnRH release [2, 3], the complex anatomical architecture and surge release of LH in ovariectomized cows, and examine of the cranium presents a signi®cant barrier to the practical the dynamics of GnRH pulse generator activity in response to application of this method in adult cattle. Additionally, known modulators of LH release (suckling; neuropeptide Y push-pull perfusion techniques have been used to obtain [NPY]). In ovariectomized cows, both tonic release patterns and median eminence perfusates in the rat [4], rabbit [5], and estradiol-induced surges of GnRH and LH were highly correlat- sheep [6]; but these methods, to our knowledge, have not ed (0.95; p , 0.01).
    [Show full text]
  • 2. Endocrine Control of the Oestrous Cycle
    2. ENDOCRINE CONTROL OF THE OESTROUS CYCLE Introduction 2.1 The cyclic changes that occur in the female reproductive tract are initiated and regulated by the hypothalamic-pituitary-ovarian (HPO) axis. Although folliculogenesis occurs independently of hormonal stimulation up until the formation of early tertiary follicles, the gonadotrophins luteinising hormone (LH) and follicle stimulating hormone (FSH) are essential for the completion of follicular maturation and development of mature preovulatory (Graafian) follicles. The sites of production and key functions of the major reproductive hormones in the female rat are summarised in Table 2.1. Pituitary gonadotrophin secretion drives follicular maturation and oestrogen secretion 2.2 Levels of LH and FSH begin to increase just after dioestrus. Both hormones are secreted by the same secretory cells (gonadotrophs) in the pars distalis of the anterior pituitary (adenohypophysis). FSH stimulates development of the zona granulosa and triggers expression of LH receptors by granulosa cells. LH initiates the synthesis and secretion of androstenedione and, to a lesser extent, testosterone by the theca interna; these androgens are utilised by granulosa cells as substrates in the synthesis of oestrogen. Pituitary release of gonadotrophins thus drives follicular maturation and secretion of oestrogen during prooestrus. 2.3 Gonadotrophin secretion by the anterior pituitary is regulated by luteinising hormone-releasing hormone (LHRH), produced by the hypothalamus. LHRH is transported along the axons of hypothalamic neurones to the median eminence where it is secreted into the hypothalamic-hypophyseal portal system and transported to the anterior pituitary. The hypothalamus secretes LHRH in rhythmic pulses; this pulsatility is essential for the normal activation of gonadotrophs and subsequent release of LH and FSH.
    [Show full text]
  • Closing in on the Mechanisms of Pulsatile Insulin Secretion
    Diabetes Volume 67, March 2018 351 Closing in on the Mechanisms of Pulsatile Insulin Secretion Richard Bertram,1 Leslie S. Satin,2 and Arthur S. Sherman3 Diabetes 2018;67:351–359 | https://doi.org/10.2337/dbi17-0004 Insulin secretion from pancreatic islet b-cells occurs in b-cells within islets of Langerhans. Although such rhythms a pulsatile fashion, with a typical period of ∼5min.The are ubiquitous across species, we focus on mice, where most basis of this pulsatility in mouse islets has been inves- of the research on b-cell oscillations has been focused. We tigated for more than four decades, and the various theories anticipate that over the next decade much of what we now have been described as either qualitative or mathematical know about mouse islets will be tested in human islets. models. In many cases the models differ in their mech- Pulsatility in insulin secretion reflects oscillations in the anisms for rhythmogenesis, as well as other less important intracellular Ca2+ concentration of islet b-cells, which in PERSPECTIVES IN DIABETES details. In this Perspective, we describe two main classes of fl 2+ turn re ect bursting electrical activity (5). In intact islets, models: those in which oscillations in the intracellular Ca several types of oscillations are commonly observed. Slow concentration drive oscillations in metabolism, and those oscillations have periods typically between 4 and 6 min (Fig. in which intrinsic metabolic oscillations drive oscillations 1A). Fast oscillations are observed in other islets, with peri- in Ca2+ concentration and electrical activity. We then dis- ods typically less than 1 min (Fig.
    [Show full text]
  • PDF-Document
    Walker, JJ., Terry, JR., Tsaneva-Atanasova, KT., Armstrong, SP., McArdle, CA., & Lightman, SL. (Accepted/In press). Encoding and decoding mechanisms of pulsatile hormone secretion. http://hdl.handle.net/1983/1617 Early version, also known as pre-print Link to publication record in Explore Bristol Research PDF-document University of Bristol - Explore Bristol Research General rights This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/ Encoding and decoding mechanisms of pulsatile hormone secretion Jamie J. Walker a, †, John R. Terry a, Krasimira Tsaneva-Atanasova a, Stephen P. Armstrong b, Craig A. McArdle b and Stafford L. Lightman b aBristol Centre for Applied Nonlinear Mathematics, Department of Engineering Mathematics, University of Bristol, Bristol, UK. bHenry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, University of Bristol, Bristol, UK. †[email protected] June 2010 Abstract Ultradian pulsatile hormone secretion underlies the activity of most neuroendocrine sys- tems, including the hypothalamo-pituitary adrenal (HPA) and gonadal (HPG) axes, and this pulsatile mode of signalling permits the encoding of information through both amplitude and frequency modulation. Thus in the HPA axis, glucocorticoid pulse ampli- tude increases in anticipation of waking, and in the HPG axis changing gonadotrophin- releasing hormone (GnRH) pulse frequency is the primary means by which the body alters its reproductive status during development. The prevalence of hormone pulsatility raises two crucial questions: how are ultradian pulses encoded (or generated) by these systems, and how are these pulses decoded (or interpreted) at their target sites? We have looked at mechanisms within the HPA axis responsible for encoding the pulsatile mode of glucocorticoid signalling that we observe in vivo.
    [Show full text]
  • The in Vivo Regulation of Pulsatile Insulin Secretion
    Diabetologia /2002) 45: 3±20 Ó Springer-Verlag 2002 Reviews The in vivo regulation of pulsatile insulin secretion N. Pùrksen1 1 Medical Department of Endocrinology and Metabolism, Aarhus University Hospital, Noerrebrogade, 8000 Aarhus C, Denmark Abstract insulin release have not been reviewed previously. This review will focus on the importance of the secre- The presence of oscillations in peripheral insulin con- tory bursts to overall insulin release, and on how insu- centrations has sparked a number of studies evaluat- lin secretion is adjusted by changes in these secretory ing the impact of the insulin release pattern on the ac- bursts. Detection and quantification of secretory tion of insulin on target organs. These have convinc- bursts depend on methods, and the methodology in- ingly shown that equal amounts of insulin presented volved in studies dealing with pulsatile insulin secre- to target organs have improved action when deliv- tion is described. Finally, data suggest that impaired ered in a pulsatile manner. In addition, impaired pulsatile insulin secretion is an early marker for /not absent) pulsatility of insulin secretion has been beta-cell dysfunction in Type II diabetes, and the demonstrated in Type II /non-insulin-dependent) di- role of early detection of impaired pulsatility to pre- abetes mellitus, suggesting a possible mechanism to dict diabetes or to examine mechanisms to cause explain impaired insulin action in Type II diabetes. beta-cell dysfunction is mentioned. [Diabetologia Whereas the regulation of overall insulin secretion /2002) 45: 3±20] has been described in detail, the mechanisms by which this regulation affects the pulsatile insulin Keywords Insulin, pulsatility oscillation, diabetes, secretory pattern, and the relative and absolute con- physiology, secretion, regulation, C peptide.
    [Show full text]
  • By Pulsatile Gonadotropin-Releasing Hormone Injections in Male Rats Modulation by Testosterone Alfredo Garcia, Melissa Schiff, and John C
    Regulation of Pituitary Gonadotropin- releasing Hormone Receptors by Pulsatile Gonadotropin-releasing Hormone Injections in Male Rats Modulation by Testosterone Alfredo Garcia, Melissa Schiff, and John C. Marshall Division of Endocrinology and Metabolism, Department of Internal Medicine, University ofMichigan, Ann Arbor, Michigan 48109 Abstract. The pattern of the gonadotropin- on the serum T concentration. With one T implant, releasing hormone (GnRH) stimulus is critically impor- increasing GnRH doses per pulse stimulated GnRH-R tant in the regulation of pituitary gonadotropin secretion in a linear manner and the maximum receptor concen- and continuous infusions down-regulate secretion while tration (703±99 fmol/mg) was seen after the 250 ng intermittent pulses maintain luteinizing hormone (LH) GnRH dose. In the presence of two T implants, GnRH- and follicle-stimulating hormone (FSH) responsiveness. R was maximal (705±45 fmol/mg) after the 25-ng dose We examined the effects of pulsatile GnRH administra- and higher doses did not increase receptors above control tion on pituitary GnRH receptors (GnRH-R) and go- values. With four T implants, GnRH doses of 5 ng nadotropin secretion in the presence of physiological induced a maximum response, 17-50 ng/pulse did not concentrations of testosterone (T) to elucidate the mech- increase GnRH-R, but receptors were again increased anisms and sites of action of GnRH and T on the by the 250-ng dose (633±86 fmol/mg). pituitary gonadotroph. After 48 h of pulsatile GnRH administration there Castrate male rats received one, two, or four testos- was no correlation between the number of GnRH-R terone (T) implants (serum T concentrations of 1.1, 2.4, and LH responses to GnRH.
    [Show full text]
  • Age-Related Change of Pulsatile Gonadotropin Secretion in Turner Syndrome
    003 1-399819 1/2902-0 196$03.00/0 PEDIATRIC RESEARCH Vol. 29, No. 2, 1991 Copyright O 1991 International Pediatric Research Foundation, Inc. Printed in (I.S. A. Age-Related Change of Pulsatile Gonadotropin Secretion in Turner Syndrome AKIO HOSODA, KENJI FUJIEDA, NOBUO MATSUURA, AKIHIRO OKUNO, AND KENJI YURI Department ofpediatrics, Hokkaido University, School of Medicine, Sapporo, Japan ABSTRACT. In an attempt to understand the dvnamic It is a well-recognized concept that sleep-enhanced, periodic, change of the gonadotropin-releasing horm~ne-~i"tuitar~pulsatile discharge of LH is initiated in early puberty (1, 2); axis during the transitional stage from prepuberty to pu- however, there is no general agreement as to the secretory pattern berty, we investigated gonadotropin secretory patterns of gonadotropins in the prepubertal stage before appearance of using a highly sensitive assay system and frequent blood any appreciable development of secondary sexual characteristics. sampling technique in children with Turner syndrome aged In Turner syndrome, where ovarian function is genetically 5-17 y. Blood samples were collected every 20 min for 24 impaired, intensified gonadotropin secretion at the age that h in 16 cases, or every 30 min for 9 h (daytime 5 h, corresponds to puberty is also initiated in a similar but more nighttime 4 h) in nine cases. Serum LH and FSH were pronounced manner than in normal puberty (3-5). These find- measured by time-resolved fluoroimmunoassay. A 24-h ings suggest that Turner syndrome represents a typical model of profile of LH and FSH was analyzed by a computerized nature to investigate maturation of the Gn-RH-~ituitarvcom- pulse detection program (PC-PULSAR).
    [Show full text]
  • Estradiol Regulates GH-Releasing Peptide's Interactions with GH
    C Norman and others GHRP, GHRH, and SS in women 170:1 121–129 Clinical Study Estradiol regulates GH-releasing peptide’s interactions with GH-releasing hormone and somatostatin in postmenopausal women Catalina Norman, Nanette L Rollene1, Dana Erickson, John M Miles, Cyril Y Bowers2 and Johannes D Veldhuis Correspondence Endocrine Research Unit, Mayo School of Graduate Medical Education, Center for Translational Science Activities, should be addressed Mayo Clinic, Rochester, Minnesota 55905, USA, 1Division of Reproductive Endocrinology, Naval Medical Center to J D Veldhuis Portsmouth (NMCP), Portsmouth, Virginia 23708, USA and 2Endocrinology and Metabolism Section, Peptide Email Research Section, Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USA [email protected] Abstract Objective: Estrogen stimulates pulsatile secretion of GH, via mechanisms that are largely unknown. An untested hypothesis is that estradiol (E2) drives GH secretion by amplifying interactions among GH-releasing hormone (GHRH), somatostatin (SS), and GH-releasing peptide (GHRP). Design: The design comprised double-blind randomized prospective administration of transdermal E2 vs placebo to healthy postmenopausal women (nZ24) followed by pulsatile GHRH or SS infusions for 13 h overnight with or without continuous GHRP2 stimulation. Methods: End points were mean concentrations, deconvolved secretion, and approximate entropy (ApEn; a regularity measure) of GH. Results: By generalized ANOVA models, it was observed that E2 vs placebo supplementation: i) augmented mean (13-h) GH concentrations (PZ0.023), GHRH-induced pulsatile GH secretion over the first 3 h (PZ0.0085) and pulsatile GH secretion over the next 10 h (PZ0.054); ii) increased GHRP-modulated (PZ0.022) and SS-modulated (P!0.001) GH ApEn; and iii) did not amplify GHRH/GHRP synergy during pulsatile GH secretion.
    [Show full text]
  • Effect of Insulin Sensitivity on Pulsatile Insulin Secretion
    European Journal of Endocrinology (1999) 141 494–501 ISSN 0804-4643 CLINICAL STUDY Effect of insulin sensitivity on pulsatile insulin secretion MilosˇZˇarkovic´, Jasmina C´iric´, Milosˇ Stojanovic´, Zorana Penezic´,Bozˇo Trbojevic´, Milka Drezgic´ and Milica Nesˇovic´ Institute of Endocrinology, School of Medicine, University of Belgrade, Dr Subotic´a 13, 11000 Belgrade, Yugoslavia (Correspondence should be addressed to Milosˇ Zˇarkovic´; Email: [email protected]) Abstract Objective: The aim of the study was to determine whether derangements in insulin pulsatility are related to the presence of insulin resistance or whether these changes occur only in non-insulin- dependent diabetes mellitus (NIDDM). Design and methods: The study included 26 obese, 11 NIDDM and 10 control subjects. The obese group was divided into a low insulin (plasma insulin <20 mU/l, OLI, 14 subjects) and a high insulin (OHI, 12 subjects) group. For pulsatility analysis blood was sampled every 2 min for 90 min. Pulsatility analysis was carried out using the PulsDetekt program. The insulin secretion randomness was quantified using interpulse interval deviation (IpID) and approximate entropy (ApEn). ApEn and ApEn normalized by S.D. of the individual insulin time series (nApEn) were calculated. Lower values of ApEn and IpID indicate more regular secretion. Homeostasis model assessment (HOMA) was used to quantify insulin sensitivity. Results: Insulin pulses were significantly less regular in the OHI and the NIDDM groups compared with the control and the OLI groups (control: ApEn 0.54 6 0.16, nApEn 0.69 6 0.19, IpID 2.53 6 0.99; OLI: ApEn 0.64 6 0.12, nApEn 0.79 6 0.15, IpID 2.92 6 1.09; OHI: ApEn 0.88 6 0.07, nApEn 0.92 6 0.07, IpID 3.95 6 0.84; NIDDM: ApEn 0.92 6 0.16, nApEn 0.99 6 0.09, IpID 4.41 6 0.53; means 6 S.D.).
    [Show full text]